Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TRIL

Trillium Therapeutics (TRIL) Stock Price, News & Analysis

Trillium Therapeutics logo

About Trillium Therapeutics Stock (NASDAQ:TRIL)

Advanced Chart

Key Stats

Today's Range
$18.44
$18.44
50-Day Range
$17.50
$18.44
52-Week Range
$5.80
$20.96
Volume
8 shs
Average Volume
1.87 million shs
Market Capitalization
$1.94 billion
P/E Ratio
29.74
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TRIL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trillium Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

TRIL Stock News Headlines

Trillium Therapeutics Stock Price History
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
See More Headlines

TRIL Stock Analysis - Frequently Asked Questions

Trillium Therapeutics Inc. (NASDAQ:TRIL) announced its earnings results on Thursday, November, 18th. The biotechnology company reported ($0.18) earnings per share for the quarter, topping analysts' consensus estimates of ($0.19) by $0.01.

Based on aggregate information from My MarketBeat watchlists, some other companies that Trillium Therapeutics investors own include NVIDIA (NVDA), Golden Dragon (CPMD), FuelCell Energy (FCEL), Gilead Sciences (GILD), TG Therapeutics (TGTX), Inovio Pharmaceuticals (INO) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
11/18/2021
Today
7/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TRIL
CIK
1616212
Fax
N/A
Employees
33
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.62
Trailing P/E Ratio
29.74
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$59.35 million
Net Margins
N/A
Pretax Margin
-113,720.92%
Return on Equity
-23.31%
Return on Assets
-18.66%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
19.82
Quick Ratio
19.82

Sales & Book Value

Annual Sales
$150 thousand
Price / Sales
12,907.39
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.56 per share
Price / Book
7.20

Miscellaneous

Outstanding Shares
104,995,000
Free Float
95,440,000
Market Cap
$1.94 billion
Optionable
Optionable
Beta
2.08
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:TRIL) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners